KPV 15mg — Vial Spec, Reconstitution Math & COA

KPV 15mg Technical Profile & Physical Overview

The KPV research peptide is a synthetic tripeptide consisting of the amino acid sequence Lysine-Proline-Valine (Lys-Pro-Val). Derived as the C-terminal tripeptide fragment of alpha-Melanocyte-Stimulating Hormone (alpha-MSH), KPV retains significant anti-inflammatory properties without inducing melanogenesis or activating central melanocortin receptors in the manner of larger parent peptides.

A 15mg vial format is specifically prepared for research settings requiring higher throughput or multi-animal cohort dosing schemes without needing frequent batch reconstitutions. Each vial contains a sterile, lyophilized cake composed of high-purity KPV acetate salt, formulated without filler proteins or unnecessary stabilizing excipients that could interfere with cell culture assays or spectrographic analysis.

Researchers evaluating KPV utilizing murine inflammatory models or intestinal epithelial cell lines rely on exact mass uniformity. Understanding the physical mass characteristics, solubility constant, and volumetric conversion of a 15mg mass is essential for setting up controlled laboratory protocols.

PX1 Catalog Availability & Packaging Context

At PX1 Research, product catalog offerings are structured around analytical precision, strict quality control, and verified vial uniformity. While high-mass options like 15mg vials are frequently requested for large-scale institutional protocols, researchers should note our standard, inventory-ready catalog unit for single-cohort studies is currently available as the KPV 10mg lyophilized vial format.

For institutions needing 15mg mass configurations or specialized custom batch sizes, laboratory procurement managers can submit custom production requests via our wholesale peptide procurement channel. Alternatively, laboratories requiring immediate dispatch can browse our complete inventory of analytical-grade compounds across our all peptides catalog.

Regardless of whether your protocol utilizes our standard 10mg size, custom 15mg runs, or bulk institutional supply, every vial shipped from our CA and AZ facilities undergoes identical ISO 17025 lab verification, HPLC purity testing, mass spectrometry identity validation, and endotoxin screening.

Biological Mechanism & Preclinical Literature Summary

Preclinical studies suggest that KPV acts primarily as an anti-inflammatory tripeptide capable of modulating intracellular inflammatory signaling cascades. In vitro data indicate that KPV enters target cells—particularly intestinal epithelial cells—via the oligopeptide transporter PepT1 (SLC15A1). Once internalized, KPV inhibits the translocation of the nuclear factor kappa B (NF-κB) p65 subunit into the nucleus, thereby downregulating the transcription of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α.

In rodent models of chemically induced colitis (such as DSS or TNBS models), KPV administration has been researched for its potential in modulating mucosal inflammation, maintaining intestinal tight junction protein expression (including ZO-1 and Occludin), and preserving epithelial barrier integrity. Because KPV lacks the full melanocortin receptor activation profile of alpha-MSH, it provides a targeted molecular tool for investigating localized mucosal immune modulation without confounding systemic endocrine responses.

Furthermore, in vitro assays investigating dermal and mucosal wound healing models indicate that KPV exerts antimicrobial activity against opportunistic pathogens like Staphylococcus aureus and Candida albicans at millimolar concentrations, presenting a dual-action mechanism of interest in inflammatory tissue barrier research.

Reconstitution Mathematics for a 15mg KPV Vial

Accurate reconstitution of a 15mg KPV vial requires precise volumetric calculations to achieve target microgram-per-microliter (µg/µL) working concentrations. Because KPV exhibits high aqueous solubility, it readily dissolves in standard laboratory diluents such as sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile Phosphate-Buffered Saline (PBS, pH 7.4).

Below are the calculated final concentration metrics when adding 1.0 mL, 2.0 mL, or 3.0 mL of diluent to a dry 15mg (15,000 µg) KPV cake:

• Reconstitution with 1.0 mL Diluent: Yields a final concentration of 15.0 mg/mL (15.0 µg/µL). In standard laboratory volumetric measurement, a 10 µL draw contains exactly 150 µg of active tripeptide.

• Reconstitution with 2.0 mL Diluent: Yields a final concentration of 7.5 mg/mL (7.5 µg/µL). A 10 µL draw contains exactly 75 µg of active tripeptide.

• Reconstitution with 3.0 mL Diluent: Yields a final concentration of 5.0 mg/mL (5.0 µg/µL). A 10 µL draw contains exactly 50 µg of active tripeptide.

For custom concentration calculations or alternative diluent volume requirements, investigators are encouraged to utilize the PX1 interactive peptide reconstitution calculator tool to verify precision prior to laboratory fluid addition.

Aliquot Planning & In Vitro Handling Workflows

To preserve structural integrity and prevent degradation caused by repeated freeze-thaw cycles, a 15mg reconstituted vial should be systematically sub-aliquoted immediately following initial liquid introduction. Repeated thermal cycling of peptide solutions causes peptide bond hydrolysis, aggregation, and loss of functional concentration.

When preparing working aliquots, investigators should utilize sterile, polypropylene low-binding micro-centrifuge tubes to minimize non-specific peptide adsorption to container walls. Aliquot volumes should be calculated based on daily assay throughput requirements (e.g., 50 µL to 200 µL per tube).

Reconstitution protocol: Gently inject the chosen diluent down the glass inner wall of the vial under laminar flow hood conditions. Allow the liquid to naturally saturate the lyophilized cake for 2–3 minutes. Swirl the vial with a gentle circular motion until complete dissolution is achieved. Avoid violent agitation, vigorous shaking, or vortexing, which can introduce shear stress and denature sensitive peptide chains.

Storage Parameters: Lyophilized Powder vs. Reconstituted Solution

Storage requirements for KPV depend directly on whether the compound is in its dry lyophilized state or reconstituted liquid state. Strict temperature control prevents chemical degradation pathways such as oxidation and deamidation over time.

Lyophilized Storage: Unopened 15mg KPV vials stored at -20°C in a desiccated, dark environment maintain chemical stability for up to 24 months. For long-term archival storage exceeding two years, ultra-low refrigeration at -80°C is recommended. Avoid exposure to direct light and ambient humidity.

Reconstituted Storage: Once dissolved in sterile Bacteriostatic Water, the liquid solution should be refrigerated at 2°C to 8°C and utilized within 28 days. If reconstituted in non-preserved sterile 0.9% Normal Saline or PBS, the solution must be used immediately or sub-aliquoted and stored at -20°C to -80°C. Frozen aliquots are stable for up to 6 months; once an aliquot is thawed, any unused portion should be discarded rather than refrozen.

Quality Assurance, HPLC Purity & Lot-Matched COA Verification

Every research compound distributed by PX1 Research undergoes rigorous, independent third-party analytical testing to guarantee purity and batch-to-batch consistency. We enforce a minimum purity threshold of >98.0% for all catalog peptides, verified via high-performance liquid chromatography (HPLC) and mass spectrometry (MS).

Laboratory buyers can review chemical integrity by accessing our certificate of analysis database. Every lot-matched COA provides verifiable documentation, including:

• HPLC Chromatogram: Confirming high chromatographic purity and detailing exact peak integration area, verifying freedom from synthesized impurities or truncation fragments.

• Mass Spectrometry (ESI-MS): Confirming the exact molecular weight of the KPV molecule (383.48 g/mol for the free base / corresponding salt mass) to verify correct sequence identity.

• Bacterial Endotoxin Testing: Quantitative LAL assay confirmation ensuring endotoxin levels remain strictly below <0.01 EU/mg, preventing confounding immune activation in delicate cell culture assays.

All PX1 peptides are manufactured in GMP-compliant, USA-based facilities and verified by accredited ISO 17025 analytical laboratories.

Comparative Analysis: KPV vs. Related Inflammatory Research Compounds

When designing preclinical protocols investigating tissue barrier repair and acute inflammatory pathways, researchers frequently compare KPV against other prominent anti-inflammatory and barrier-modulating peptides. Selecting the appropriate research agent depends on the specific receptor pathway or physiological tissue model under investigation.

In intestinal permeability and mucosal repair research, KPV is often evaluated alongside compounds such as BPC-157, Larazotide acetate, and VIP (Vasoactive Intestinal Peptide). While BPC-157 operates largely through VEGFR2 modulation and focal adhesion kinase pathways to promote angiogenesis and tissue repair, KPV focuses directly on mucosal PepT1-mediated transport and intracellular NF-κB inhibition. Larazotide acetate acts primarily as a tight-junction antagonist blocking zonulin receptors, whereas VIP functions via G-protein coupled receptors (VPAC1/VPAC2) to regulate immune cell cytokine production.

Understanding these distinct mechanism profiles allows researchers to construct targeted single-agent assays or orthogonal combination protocols evaluating multifaceted inflammatory responses.

Determining Vial Mass Selection: 10mg vs. 15mg vs. Bulk Formats

Selecting the appropriate vial mass configuration is a critical planning step for managing lab research budgets, minimizing reagent waste, and ensuring experimental reproducibility. Choosing between standard 10mg vials, 15mg vials, or bulk custom manufacturing depends on specific assay design parameters:

• Single-Cohort or In Vitro Pilot Screen: For smaller cell culture assays or exploratory pilot studies, smaller vial formats like the KPV 10mg minimize liquid shelf-life concerns and allow researchers to use fresh reconstituted material for every experimental phase.

• High-Throughput & In Vivo Animal Studies: Multi-animal cohorts or high-concentration daily dosage schedules benefit from 15mg or larger vial sizes. Preparing larger uniform batches reduces volumetric pipette variance across microplate wells or animal treatment groups.

• Enterprise & Institutional Procurement: Research facilities conducting high-volume long-term studies can access scaled volume pricing, custom fill weights, and dedicated batch reservations by contacting our team via the wholesale research peptide supply portal.

To explore comprehensive scientific literature, study protocols, and technical resources on tripeptides and structural fragments, visit the central PX1 peptide research hub.